Results 141 to 150 of about 6,571 (196)

YBX1-Mediated Activation of SREBP2 Drives Sorafenib Resistance via Cholesterol Biosynthesis in Hepatocellular Carcinoma

open access: yes
Background: Hepatocellular carcinoma (HCC) is an aggressive, largely chemo-resistant cancer with a poor prognosis and is the leading cause of cancer-related deaths worldwide. Currently, there is no effective systemic chemotherapy for HCC.
Hussain, Shaibir   +6 more
core  

YBX1 Expression Marks Proliferative Tumour States with Context-Dependent Genomic Instability: A Pan-Cancer Analysis. [PDF]

open access: yesInt J Mol Sci
Wang S   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy